Surmodics Inc (SRDX): קונצנזוס שווי הוגן
Surmodics, Inc. (SRDX) supplies specialized coatings for pacemaker and stent manufacturers, leveraging patent protection to capture market share in the medtech sector. This price chart reflects a consensus forecast of 43.03, while risks are tied to a limited customer base and potential clinical trial failures. Stable cash flow and long-term royalties provide sustainable demand inertia for the company's innovations.
%20-%20%D7%AA%D7%97%D7%96%D7%99%D7%AA%20%D7%A7%D7%95%D7%A0%D7%A6%D7%A0%D7%96%D7%95%D7%A1%20%D7%90%D7%A0%D7%9C%D7%99%D7%A1%D7%98%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvj9owew.wip-79mfnr4&start=20220704&end=20261022&filename=GURU_Markets_-_SRDX_-_Surmodics-Inc._-_Analyst-Consensus-Forecast "SRDX - תחזית משוקללת של בתי השקעות surmodics.com בטווח 04.07.2022 - 29.11.2025 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת Surmodics Corp (SRDX)
The strong pricing power of Surmodics, Inc. (SRDX), driven by patents for critical catheter coatings, establishes a foundation for stable business value growth. The trend in the average market price target aggregates institutional analyst expectations, revealing a gap between the current share price and fundamental value, which allows investors to timely identify hidden risks of capital stagnation or the potential for asset undervaluation.